Orthocell Share Price and Company Fundamentals
Last traded: Today at 3:45 AM
Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair and regeneration of human tendon, bone, nerve, and cartilage defects in Australia. The company's principal products include CelGro, a naturally derived collagen medical device for soft tissue repair that is under clinical trials for use as an augment to the surgical repair of tendons, peripheral nerves, bones, and articular cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation for the treatment of symptomatic defects of the articulating cartilage of the joints, primarily in the knee and ankle. Orthocell Limited was founded in 2006 and is based in Murdoch, Australia.
|Primary activities||Regenerative medicine sector for chronic degenerative diseases and injury.|
|Industry / Sector||Biotechnology / Healthcare|
|Mailing address||Murdoch University Building 191 South Street Murdoch WA 6150 Australia|
|Phone / Fax||61 8 9360 2888 / 61 8 9360 2899|
|Share registry||AUTOMIC REGISTRY SERVICES|
Orthocell does not pay dividends.
As of May 2021, following are the company executives and directors listed on Orthocell.
|Dr. Stewart James Washer B.Sc., BSc (Hons), Ph.D.||Exec. Chairman||50||150k|
|Mr. Paul Anderson||CEO, MD & Exec. Director||54||495.55k|
|Ms. Leslie Wise J.D.||Exec. Director||68.18k|
|Ms. Nicole Jane Telford||Chief Financial Officer|
|Mr. Alex McHenry||Chief Operating Officer|
|Prof. Ming Hao Zheng||Chief Scientific Officer and Member of Medical & Scientific Advisory Board|
|Mr. Simon Lee Robertson B.Bus, CA, M Appl. Fin.||Company Sec.||60|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Orthocell is 98.38M and its enterprise value is 82.71M. The enterprise value to revenue ratio of OCC is 103.70.
The OCC's stocks Beta value is 0.36 making it 64% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Orthocell (OCC)
Orthocell (ASX:OCC) Frequently Asked Questions
1. What is Orthocell's Stock Symbol?
Orthocell trades on ASX under the ticker symbol "OCC".
2. What is Orthocell's stock price today?
One share of OCC stock can currently be purchased for approximately $0.52.
3. How can I contact Orthocell?
Orthocell's mailing address is Murdoch University Building 191 South Street Murdoch WA 6150 Australia. The company can be reached via phone at 61 8 9360 2888.
4. What is Orthocell's official website?
The official website of Orthocell is http://www.orthocell.com.au.
5. Which share registry manages Orthocell's stock?
Orthocell's stock is managed by AUTOMIC REGISTRY SERVICES.